The Global Next Generation RNA Sequencing (NGS) Market was valued at USD 3.4 billion and is projected to reach a market size of USD 10.58 billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 17.6%.
%20Market.jpg)
Earlier, RNA sequencing was done manually using traditional laboratory techniques for analyzing diseases for further development of vaccines and medicines. However, it consumed a lot of time, which resulted in errored and delayed results. Further, technological advancements in RNA sequencing produced results that were error-free, required less human intervention, and offered cost-effective sequencing methods such as nanopore sequencing, small RNA sequencing, single-cell RNA sequencing, and others. Moreover, rising demand for precision medicines and treatments further enhanced the market opportunities of many companies dealing in RNA sequencing. Furthermore, the next generation RNA sequencing market is anticipated to witness positive growth in the market on account of continuous technological developments in sequencing techniques with increased incorporation of data analytics tools and high-end software for storing genomic research data.
Key Market Insights:
According to Prolix Research, a clinical research organization in the USA, personalized medicine therapies accounted for 39% of new drugs approved by the United States Food and Drug Administration in the year 2020.
As per WHO, genetic disorders and congenital abnormalities occur in all live births around 2-5%.
Furthermore, according to WHO, 10 out of 1000 people are affected by single-gene diseases.
Next Generation RNA Sequencing (NGS) Market Drivers:
The increasing demand for personalized medicine has boosted the demand for Next Generation RNA Sequencing (NGS) in the market.
The demand for personalized medicine has increased due to patient’s preferring tailormade medical treatments that involve their engagement and provide speedy treatment of the disease. Moreover, Next Generation RNA Sequencing (NGS) has made it easier for researchers, doctors, scientists, and other health and medical professionals to prepare targeted therapies based on the data obtained. In addition, RNA sequencing enables clinicians and doctors in treatment selection of chronic diseases such as cancer, and monitor the disease progress once medical intervention is performed. Furthermore, RNA sequencing helps in the discovery of targeted novel drugs and vaccines for potential disease outbreak in the future.
Technological advancements in sequencing technologies have boosted the demand for Next Generation RNA Sequencing (NGS) in the market.
Technological advancements in the field of gene sequencing have made the process cost-effective, error-free, efficient, and reliable for researchers. Moreover, the increased prevalence of RNA sequencing platforms such as illumine and the incorporation of nanotechnology in RNA sequencing, such as nanopore sequencing has made it easier to study smallest of molecules and determine target disease for biomarkers development. Moreover, improvements in transcription of RNA such as the development of longer and ultra-long read lengths has further improved the sequencing process. Furthermore, trends in data analytics have further developed the market landscape for Next Generation RNA Sequencing (NGS), as bioinformatics tools and real-time sequencing tools enable researchers, clinicians, and scientists to reduce biases and errors during the sequencing process, and efficiently manage the genomic data using cloud-based data management and storage software.
Next Generation RNA Sequencing (NGS) Market Restraints and Challenges:
Cost implications associated with RNA sequencing products could pose hinderance for the growth of Next Generation RNA Sequencing (NGS) Market.
Expensive cost of certain RNA sequencing products such as machines, equipment, technologically- advanced tools and services can decline the demand for Next Generation RNA Sequencing (NGS) in the market.
Data Security issues of genomic data could prove a lot more challenging for businesses.
Data leak or privacy leak can deter the market demand for NGS in the market. Modern RNA sequencing tools and services offers management and storage of genomic data on online platform such as cloud-based software, which is prone to cyber-attacks such as misuse of data, data breach, and others, leading to decline in demand for NGS in the market.
Next Generation RNA Sequencing (NGS) Market Opportunities:
The Next Generation RNA Sequencing (NGS) market is witnessing an upward turn in the market due to increasing demand for targeted treatments, especially for chronic disease such as tumour and cancer. In addition, the emerging gene-tech start-ups in sequencing industry is further opening various opportunities for the growth of the market, as technology-enabled RNA sequencing requires minimal human intervention and reduces errors completely by deploying various RNA sequencing such as RNA isolation and library preparation.
NEXT GENERATION RNA SEQUENCING (NGS) MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 - 2030 |
|
Base Year |
2023 |
|
Forecast Period |
2024 - 2030 |
|
CAGR |
17.6% |
|
Segments Covered |
By Technology, Application, Sample Source, Product & Service, End-User, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Genewiz, Illumina, Biocompare, Integrated DNA Technologies, Nucleome Informatics, Qiagen, Thermo Fisher Scientific, CD Genomics, BGI Genomics, Novogene, Eurofins Genomics |
Sequencing by Synthesis
Ion Semiconductor Sequencing
Nanopore Sequencing
Single-Molecule Real-Time Sequencing
In 2022, based on market segmentation by technology, sequencing by synthesis occupied the highest share of about 34% in the market. Sequencing synthesis is the most common method of sequencing RNA which involves the use of nucleotide bases to grow the complementary strand of RNA. Moreover, it helps researchers understand which genes are causing differences in the cells or tissues. Additionally, illumine platforms are majorly used for RNA sequencing, as it helps in simplifying the process of sequencing by integration of whole-transcriptome sequencing workflows. Additionally, it can generate large amounts of data within a short period of time with low error rates. Furthermore, the growth of this segment is attributed to increase in demand from epigentic studies, for transcriptome profiling, and others.
Nanopore sequencing is the fastest-growing during the forecast period. This technology involves passage of RNA molecules from nanopores that enables the study of any fragment of molecule, from short to ultra-long length. In addition, its popularity in the biotechnology field is due to the real-time analysis of molecules and rapid delivery of insights. Furthermore, it enables direct sequencing of RNA molecules, which can help researchers and bio scientists reduce errors during reverse transcription. Further, it is widely used in RNA transcriptome analysis, RNA modification detection, de novo sequencing, and others.
De Novo Transcriptome Assembly
Variant calling and Transcriptome Epigenetics
Small RNA-Sequencing
Expression Profiling Analysis
In 2022, based on market segmentation by application, de novo sequencing occupied the highest share of about 28% in the market. De novo transcriptome assembly is used to study non-model organisms and when a genome is not available. Moreover, it is widely used by researchers for reading sequence from the same or other experiments for determining differential gene expression and for exploring genetic diversity. Furthermore, the growth of this segment is attributed due to its cost-effectiveness in genome building and the ability to discover new genes in varies studies.
Small RNA-sequencing is the fastest-growing segment during the forecast period. Small RNA-sequencing is method of isolating and sequencing small species of RNA for studying biological processes. Moreover, it also helps in investigating microRNAs that have high sensitivity and resolution. Furthermore, sRNA helps in discovering novel transcripts of sRNA, identifies tissue and cell-specific biomarkers for diagnosis of various diseases such as cancer and others. In addition, it also helps in understanding tissue and organism development base don the transcript data obtained.
Environmental/Microbial
Animal
Plant
Human
In 2022, based on market segmentation by sample source, human occupied the highest share of about 29% in the market. Studying human sample is critical for medical and clinical search, as it helps to study the response to potential drug interventions, clinical trials, and in identifying target biomarkers for disease diagnosis, such as analyzing potential virus mutations or other infections in the human body. This further helps healthcare professionals in devising personalized medicine and treatment procedures.
The plant segment is the fastest-growing segment during the forecast period. Plant samples consists of samples of soil, crops, leaves, and others for studying the environment, crop growth, and breeding mechanisms of specific plants. Moreover, increased demand for efficient crop growth and faster crop yield has boosted the demand for plant RNA sequencing that enables agricultural scientists and researchers analyze the genetic expression of a particular plant, determine its growth based on the surrounding environment, responsiveness to potential climatic conditions, and others.
Sample Preparation Products
RNA-Sequencing Services
RNA Sequencing Platforms & Consumables
Data Analysis, Storage, and Management
In 2022, based on market segmentation by product & service, RNA-sequencing products occupied the highest share of about 36% in the market. RNA sequencing services are increasingly demanded by researchers, scientists, and biotechnologists for genomic research purposes. These services are provided by various biopharmaceutical companies, gene sequencing companies, and service providers, which include RNA isolation, library construction services, quality controlling, real-time data analysis services with integration capabilities, customized experimental tools and project management services.
Data analysis, storage, and management is the fastest-growing region during the forecast period. These services are highly-demanded by clinical researchers, doctors, and other healthcare professionals for efficient and quality management of RNA sequencing data, which includes genetic history, gene transformation information, disease diagnosis, and others. Further, data analysis, storage, and management services are increasingly demanded due to growing trends in cloud storage services by researchers and scientists. Moreover, rising number of cyber-attacks has induced hospitals and diagnostic centers to deploy highly-secured and data compliant data management and storage software. In addition, there is an increasing demand for bioinformatics tools and software for genetic data analysis purpose, as it helps to reduce human error and helps in identifying different gene transcripts efficiently.
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Research & Academia
Others
In 2022, based on market segmentation by end-user, hospitals & clinics occupied the highest share of about 37% in the market. Hospitals & clinics are major users of Next Generation RNA Sequencing (NGS) services for diagnosing and monitoring diseases that further help them device personalized treatment and medicine solutions for patients. Furthermore, it enables doctor and other healthcare professionals analyze the disease spread based on historical genetic data.
Pharmaceutical & biotechnology companies are the fastest-growing segment during the forecast period. Next Generation RNA Sequencing (NGS) enables these companies to prepare targeted drug formulations, perform clinical trials, and analyze patients’ response to potential drug interventions based on genetic data obtained. In addition, Next Generation RNA Sequencing (NGS) helps pharmaceutical & biotechnology companies to develop vaccines and drugs for curbing future virus infections based on the genomic data obtained. Additionally, it also helps bio pharmacists, monitor drug effects and efficiency on gene expressions.
North America
Europe
Asia-Pacific
South America
Middle-East & Africa
In 2022, based on market segmentation by region, North America occupied the highest share of about 40% in the market. Continuous research and development in personalized medicines and treatment procedures, and increasing demand for clinical trials of novel drugs for rare and chronic diseases have contributed to the demand for Next Generation RNA Sequencing (NGS) in the region.
Asia-Pacific will witness faster growth during the forecast period. Increased demand for agricultural research and development for analyzing crop growth and yield, environmental conditions, and soil fertility has contributed to the demand for Next Generation RNA Sequencing (NGS) in the region.
COVID-19 Impact Analysis on the Next Generation RNA Sequencing (NGS) Market
The pandemic had a positive impact on the next generation RNA sequencing market. During the pandemic, there was an increase in demand for RNA sequencing tools for understanding the COVID-19 virus structure, its mutation, and potential health impact on patients. Moreover, these tools enabled researchers to develop vaccines and medicines for targeting virus infection. In addition, social distancing measures raised the demand for online RNA sequencing tools and software that provided data storage and management services to the healthcare professionals. Moreover, it enabled pharmaceutical institutes develop targeted drugs based on the gene sample, patient’s immunity response to potential drug intervention, and others.
Latest Developments:
Key Players:
Genewiz
Illumina
Biocompare
Integrated DNA Technologies
Nucleome Informatics
Qiagen
Thermo Fisher Scientific
CD Genomics
BGI Genomics
Novogene
Eurofins Genomics
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The Global Next Generation RNA Sequencing (NGS) Market was valued at USD 3.4 billion and is projected to reach a market size of USD 10.58 billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 17.6%.
The increasing demand for personalized medicine and Technological advancements in sequencing technologies are the market drivers of the Next Generation RNA Sequencing (NGS) market.
Environmental/Microbial, Animal, Plant, and Human, are the segments under the Next Generation RNA Sequencing (NGS) Market by sample source.
North America is the most dominant region for the Next Generation RNA Sequencing (NGS) Market.
Genewiz, Illumina and Biocompare are few of the leading players in the Next Generation RNA Sequencing (NGS) Market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
